Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

ALB vs SOLS: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

ALB Wins Head-to-Head Institutional Verdict (3–3 across 6 Pillars · 7–2 Matrix Metrics)

ALB Overall Winner 6-Pillar Tally: ALB 3 – 3 SOLS Matrix Metrics: ALB 7 – 2 SOLS

As of Nov 16, 2026, Albemarle Corporation (ALB) is the stronger overall head-to-head candidate over Solstice Advanced Materials Inc. (SOLS) in the Tradestie Institutional Equity Comparison Engine, winning 7–2 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Balance Sheet & Cash Flow). ALB carries a Unified Composite Score of 57.8/100 (HOLD) at $88.16 (11.5x Forward P/E, 17.1% operating margin), whereas SOLS carries 34.5/100 (SELL) at $64.92 (19.3x Forward P/E, 17.2% operating margin).

  • Technical & Structure Timing Caution: ALB is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 34.7); meanwhile SOLS is in a Breakdown options structure phase (RSI 55.8). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About ALB vs SOLS
ALB NYSE Head-to-Head Winner
Albemarle Corporation
Plastic Materials, Synth Resins & Nonvulcan Elastomers
$88.16
-5.74% 1D
Market Cap $11.0B
TTM Revenue $4.42B
Forward P/E 11.5x
Beta / 30D Vol 0.95β · 45% Vol
Unified Composite Score
57.8 / 100 HOLD
Tech 37.0 Fund 53.0 Flow 58.0 Mom 64.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -13.4%), weak momentum, RSI 35
RSI-14: 34.7 · SMA20: $94.53 · SMA50: $102.81
SOLS US Equity
Solstice Advanced Materials Inc.
Chemicals & Allied Products
$64.92
-1.81% 1D
Market Cap $10.4B
TTM Revenue $4.17B
Forward P/E 19.3x
Beta / 30D Vol 1.66β · 67% Vol
Unified Composite Score
34.5 / 100 SELL
Tech 8.0 Fund 31.0 Flow 58.0 Mom 31.4
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (1.4% over 20 days), RSI 56
RSI-14: 55.8 · SMA20: $62.07 · SMA50: $60.31

6-Pillar Scorecard Institutional Category Breakdown (ALB 3 – 3 SOLS)

Columns: Metric · ALB · SOLS
1. Valuation Multiples ALB
Forward P/E 11.5x 19.3x
Trailing P/E 22.5x 32.4x
PEG Ratio 0.79x 0.39x
EV / Revenue 2.5x 2.9x
2. Growth & Scale ALB
Revenue Growth (YoY) +18.8% +7.9%
Earnings Growth (YoY) -66.2% +22.8%
TTM Revenue (USD) $4.42B $4.17B
Market Cap $11.0B $10.4B
3. Profitability & Quality SOLS
Gross Margin 26.2% 30.9%
Operating Margin 17.1% 17.2%
Net Profit Margin 11.1% 7.8%
Return on Equity (ROE) 7.0% 16.0%
4. Balance Sheet & Cash Flow ALB
Cash Generation (TTM) $1.04B $427M
Cash Flow Margin 23.5% 10.2%
Net Cash / Leverage $25M Net Debt (0.18x D/E) $1.70B Net Debt (1.55x D/E)
Dividend Yield 1.71% 0.34%
5. Options & Positioning SOLS
Options Structure Phase BREAKDOWN BREAKDOWN
Current IV / %ile 59.5% (26th %ile) 62.0% (22nd %ile)
Put/Call OI Skew 0.53x (Call-Skewed) 0.11x (Call-Skewed)
OBV Trend / Tech Phase NEUTRAL · Markdown ACCUMULATION · Markup
6. R&D & Supply-Chain Moat SOLS
OpEx & R&D Intensity 9.1% of Rev ($402M) 13.7% of Rev ($572M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Scale & Operating Efficiency Moat Scale & Operating Efficiency Moat
Supply-Chain Role Specialty Chemicals Operator Specialty Chemicals Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: ALB (7) vs SOLS (2)
Institutional Metric ALB SOLS Criterion Row Edge
Market Capitalization
Scale
$11.0B $10.4B Larger Scale ALB
Trailing P/E Ratio
Valuation
22.5x 32.4x Lower Multiple ALB
Forward P/E Ratio
Valuation
11.5x 19.3x Lower Multiple ALB
Revenue Growth (YoY)
Growth
+18.8% +7.9% Higher Growth ALB
Operating Margin (TTM)
Profitability
17.1% 17.2% Higher Margin Tie
Net Profit Margin
Profitability
11.1% 7.8% Higher Margin ALB
Return on Equity (ROE)
Capital Efficiency
7.0% 16.0% Higher ROE SOLS
52-Week Range Position
Momentum
0% ($88–$221) 49% ($40–$91) Stronger Trend SOLS
Beta / 30D Volatility
Risk Regime
0.95β · 45% Vol 1.66β · 67% Vol Lower Realized Risk ALB
Unified Institutional Score
Composite Signal
57.8 / 100 (HOLD) 34.5 / 100 (SELL) Higher Composite ALB
Trailing 12M Revenue (USD)
Operating Scale
$4.42B $4.17B FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
26.2% 30.9% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
0.79x PEG · 2.5x EV/Rev 0.39x PEG · 2.9x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$1.04B ($25M Net Debt (0.18x D/E)) $427M ($1.70B Net Debt (1.55x D/E)) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon SOLS +17.24 pp
ALB: -7.67% · SOLS: +9.57%
3M Horizon SOLS +41.61 pp
ALB: -33.57% · SOLS: +8.04%
6M Horizon SOLS +28.93 pp
ALB: -49.83% · SOLS: -20.9%
1Y Horizon SOLS +65.01 pp
ALB: -23.05% · SOLS: +41.96%

Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant USD Revenue & Operating Margin (%)
Period ALB Revenue SOLS Revenue ALB Op. Margin SOLS Op. Margin Margin Leader
FY2018 $3.37B N/A 27.0% N/A ALB
FY2019 $3.59B N/A 18.6% N/A ALB
FY2020 $3.13B N/A 16.2% N/A ALB
FY2021 $3.33B N/A 24.0% N/A ALB
FY2022 $7.32B N/A 33.7% N/A ALB
FY2023 $9.62B $3.65B 2.6% 17.0% SOLS
FY2024 $5.38B $3.77B -33.0% 15.8% SOLS
FY2025 $5.14B $3.89B -7.1% 6.1% SOLS

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
ALB BREAKDOWN
148d in phase · OBV NEUTRAL
Current IV 59.5%
IV Percentile 26th %ile
Put/Call OI Skew 0.53x (Call-Skewed)
IV Regime Balanced (25th–60th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact ALB Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
SOLS BREAKDOWN
129d in phase · OBV ACCUMULATION
Current IV 62.0%
IV Percentile 22nd %ile
Put/Call OI Skew 0.11x (Call-Skewed)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow ACCUMULATION
Exact SOLS Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
ALB Moat Profile Scale & Operating Efficiency Moat
Specialty Chemicals Operator
Competes within the Specialty Chemicals value chain with $11.0B market capitalization and 17.1% operating margin.
OpEx & R&D Reinvestment 9.1% of Rev ($402M)
90D Engineering Disclosures 0 Published
SOLS Moat Profile Scale & Operating Efficiency Moat
Specialty Chemicals Operator
Competes within the Specialty Chemicals value chain with $10.4B market capitalization and 17.2% operating margin.
OpEx & R&D Reinvestment 13.7% of Rev ($572M)
90D Engineering Disclosures 0 Published

Investor FAQ ALB vs SOLS Key Questions & Quantitative Answers

As of Nov 16, 2026, Albemarle Corporation (ALB) is the stronger overall head-to-head candidate over Solstice Advanced Materials Inc. (SOLS) in the Tradestie Institutional Equity Comparison Engine, winning 7–2 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Balance Sheet & Cash Flow). ALB carries a Unified Composite Score of 57.8/100 (HOLD) at $88.16 (11.5x Forward P/E, 17.1% operating margin), whereas SOLS carries 34.5/100 (SELL) at $64.92 (19.3x Forward P/E, 17.2% operating margin). Technical & Structure Timing Caution: ALB is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 34.7); meanwhile SOLS is in a Breakdown options structure phase (RSI 55.8). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

ALB leads the Growth & Scale pillar: ALB posts +18.8% YoY revenue growth and -66.2% YoY earnings growth on $4.42B TTM revenue (26.2% gross margin, 17.1% operating margin), compared with SOLS at +7.9% YoY revenue growth and +22.8% YoY earnings growth on $4.17B TTM revenue (30.9% gross margin, 17.2% operating margin). Across the 8-period historical trajectory (FY2018 to FY2025), ALB cumulative revenue shifted +52.5% while SOLS shifted +6.6%. In operating R&D and SG&A reinvestment, ALB deploys 9.1% of Rev ($402M) (0 90-day corporate R&D disclosures) versus 13.7% of Rev ($572M) (0 disclosures) for SOLS.

ALB screens cheaper on headline valuation multiples. ALB trades at 11.5x Forward P/E, 22.5x Trailing P/E, 0.79x PEG, and 2.5x EV/Revenue (23.5% FCF margin), whereas SOLS trades at 19.3x Forward P/E, 32.4x Trailing P/E, 0.39x PEG, and 2.9x EV/Revenue (10.2% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against ALB (7.0% ROE) versus SOLS (16.0% ROE) capital efficiency.

In options market volatility and institutional positioning, ALB carries 59.5% implied volatility (26th %ile, Balanced (25th–60th %ile)), a 0.53x (Call-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in a BREAKDOWN options structure phase (0.95β · 45% Vol realized risk). By comparison, SOLS carries 62.0% implied volatility (22nd %ile, Compressed (<25th %ile)), a 0.11x (Call-Skewed) Put/Call open-interest ratio, ACCUMULATION on-balance volume, and sits in a BREAKDOWN options structure phase (1.66β · 67% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.